GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Sciences Inc (XKRX:291650) » Definitions » Beta

Aptamer Sciences (XKRX:291650) Beta : 0.02 (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aptamer Sciences Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-15), Aptamer Sciences's Beta is 0.02.


Aptamer Sciences Beta Historical Data

The historical data trend for Aptamer Sciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Sciences Beta Chart

Aptamer Sciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial - - - - -0.15

Aptamer Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.15 0.01 0.02 0.04

Competitive Comparison of Aptamer Sciences's Beta

For the Biotechnology subindustry, Aptamer Sciences's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Sciences's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Sciences's Beta distribution charts can be found below:

* The bar in red indicates where Aptamer Sciences's Beta falls into.



Aptamer Sciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Aptamer Sciences  (XKRX:291650) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Aptamer Sciences Beta Related Terms

Thank you for viewing the detailed overview of Aptamer Sciences's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Sciences Business Description

Traded in Other Exchanges
N/A
Address
172, Dolma-ro, Bundang-gu, 407 Ho, Healthcare Innovation Park, Gyeonggi-do, Seongnam-si, KOR, 13605
Aptamer Sciences Inc is a research and development based bio venture company. The company is focused on the Aptamer Technology Platform for the development of innovative therapeutic and diagnostic platforms. It develops and facilitates drug development and other diagnostic products.

Aptamer Sciences Headlines

No Headlines